Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Cerebromalacia

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Cerebromalacia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyko, OB; Edwards, MK; Glazier, MC; Kung, HF; Marquart, CL; Park, HM; Wellman, HN1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Cerebromalacia

ArticleYear
I-123 HIPDM SPECT imaging and cerebral angiography for EC-IC bypass evaluation.
    Radiographics : a review publication of the Radiological Society of North America, Inc, 1987, Volume: 7, Issue:3

    Topics: Adult; Carotid Artery Diseases; Cerebral Angiography; Cerebral Revascularization; Cerebrovascular Circulation; Cerebrovascular Disorders; Encephalomalacia; Female; Humans; Iodobenzenes; Male; Middle Aged; Postoperative Care; Tomography, Emission-Computed

1987